These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 1995949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
    Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T, Kaushik N, Pandey PK, Kashanchi F, Deng L, Pandey VN.
    Biochemistry; 2000 Sep 26; 39(38):11532-9. PubMed ID: 10995220
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H, He J, Fong S, Wilcox G, Wood C.
    J Virol; 2000 Mar 26; 74(6):2703-13. PubMed ID: 10684286
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
    Kessler M, Mathews MB.
    Proc Natl Acad Sci U S A; 1991 Nov 15; 88(22):10018-22. PubMed ID: 1658792
    [Abstract] [Full Text] [Related]

  • 10. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM, Sweet MJ, Ross IL, Hume DA.
    J Virol; 1993 Dec 15; 67(12):6956-64. PubMed ID: 8230418
    [Abstract] [Full Text] [Related]

  • 11. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
    Schafer SL, Vlach J, Pitha PM.
    J Virol; 1996 Oct 15; 70(10):6937-46. PubMed ID: 8794337
    [Abstract] [Full Text] [Related]

  • 12. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Rhim H, Rice AP.
    Nucleic Acids Res; 1994 Oct 25; 22(21):4405-13. PubMed ID: 7971271
    [Abstract] [Full Text] [Related]

  • 13. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M, Rimessi P, Sabbioni S, Caputo A, Balboni PG, Gualandri R, Manservigi R, Grossi MP, Barbanti-Brodano G.
    Biotechniques; 1991 Mar 25; 10(3):344-53. PubMed ID: 1829615
    [Abstract] [Full Text] [Related]

  • 14. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep 25; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA, Rabbi MF, Kagnoff MF.
    AIDS; 1997 Feb 25; 11(2):139-46. PubMed ID: 9030359
    [Abstract] [Full Text] [Related]

  • 16. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat.
    Di Luca D, Secchiero P, Bovenzi P, Rotola A, Caputo A, Monini P, Cassai E.
    AIDS; 1991 Sep 25; 5(9):1095-8. PubMed ID: 1657039
    [Abstract] [Full Text] [Related]

  • 17. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D, Elliott JF, Chang LJ.
    Gene Ther; 1995 Jun 25; 2(4):269-78. PubMed ID: 7552987
    [Abstract] [Full Text] [Related]

  • 18. Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.
    Greenberg ME, Mathews MB.
    Nucleic Acids Res; 1997 Dec 15; 25(24):5017-24. PubMed ID: 9396810
    [Abstract] [Full Text] [Related]

  • 19. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
    Popik W, Pitha PM.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9573-7. PubMed ID: 1719535
    [Abstract] [Full Text] [Related]

  • 20. Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency.
    Drysdale CM, Pavlakis GN.
    J Virol; 1991 Jun 01; 65(6):3044-51. PubMed ID: 2033665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.